Hong Kong Stock Movers: Several Innovative Drug Stocks Rally in Afternoon Trading, GENSCRIPT BIO Surges Nearly 8%, REMEGEN Gains Over 4%

Stock News

Jul 31

Several innovative drug concept stocks showed strength in the afternoon session.

As of the latest trading, XTALPI (02228) rose 7.45% to HKD 6.92; GENSCRIPT BIO (01548) climbed 6.4% to HKD 18.3; REMEGEN (09995) advanced 2.96% to HKD 81.75; and WUXI BIO (02269) increased 2.75% to HKD 38.84.

On the policy front, the Shanghai Municipal People's Government issued the "15th Five-Year Plan for Health Development in Shanghai" on July 30. The plan outlines enhanced support for the research and development of innovative drugs and medical devices. Specifically, it establishes a mechanism to exempt innovative drugs from the DRG (Diagnosis Related Groups) and DIP (Diagnosis-Intervention Packet) payment caps, sending a positive signal regarding the medical insurance reimbursement environment for these products. Furthermore, the National Essential Medicines List has, for the first time, included innovative drugs on a batch scale, which is expected to improve the clinical accessibility of domestically developed innovative drugs.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1149808402"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1149808402\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1149808402?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-31 13:50","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1149808402","market":"other","top_or_hot":-1,"title":"Hong Kong Stock Movers: Several Innovative Drug Stocks Rally in Afternoon Trading, GENSCRIPT BIO Surges Nearly 8%, REMEGEN Gains Over 4%","media":"Stock News","content":"<p>Several innovative drug concept stocks showed strength in the afternoon session.<br><br>As of the latest trading, <b>XTALPI</b> (02228) rose 7.45% to HKD 6.92; <b>GENSCRIPT BIO</b> (01548) climbed 6.4% to HKD 18.3; <b>REMEGEN</b> (09995) advanced 2.96% to HKD 81.75; and <b>WUXI BIO</b> (02269) increased 2.75% to HKD 38.84.<br><br>On the policy front, the Shanghai Municipal People's Government issued the \"15th Five-Year Plan for Health Development in Shanghai\" on July 30. The plan outlines enhanced support for the research and development of innovative drugs and medical devices. Specifically, it establishes a mechanism to exempt innovative drugs from the DRG (Diagnosis Related Groups) and DIP (Diagnosis-Intervention Packet) payment caps, sending a positive signal regarding the medical insurance reimbursement environment for these products. Furthermore, the National Essential Medicines List has, for the first time, included innovative drugs on a batch scale, which is expected to improve the clinical accessibility of domestically developed innovative drugs.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hong Kong Stock Movers: Several Innovative Drug Stocks Rally in Afternoon Trading, GENSCRIPT BIO Surges Nearly 8%, REMEGEN Gains Over 4%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHong Kong Stock Movers: Several Innovative Drug Stocks Rally in Afternoon Trading, GENSCRIPT BIO Surges Nearly 8%, REMEGEN Gains Over 4%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-07-31 13:50</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Several innovative drug concept stocks showed strength in the afternoon session.<br><br>As of the latest trading, <b>XTALPI</b> (02228) rose 7.45% to HKD 6.92; <b>GENSCRIPT BIO</b> (01548) climbed 6.4% to HKD 18.3; <b>REMEGEN</b> (09995) advanced 2.96% to HKD 81.75; and <b>WUXI BIO</b> (02269) increased 2.75% to HKD 38.84.<br><br>On the policy front, the Shanghai Municipal People's Government issued the \"15th Five-Year Plan for Health Development in Shanghai\" on July 30. The plan outlines enhanced support for the research and development of innovative drugs and medical devices. Specifically, it establishes a mechanism to exempt innovative drugs from the DRG (Diagnosis Related Groups) and DIP (Diagnosis-Intervention Packet) payment caps, sending a positive signal regarding the medical insurance reimbursement environment for these products. Furthermore, the National Essential Medicines List has, for the first time, included innovative drugs on a batch scale, which is expected to improve the clinical accessibility of domestically developed innovative drugs.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"HK0000320264.USD","symbol_name":"TAIKANG KAITAI CHINA NEW OPPORTUNITIES FUND \"A\" (USD) ACC","start_time":0,"source_url":"","article_id":"1149808402","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1149808402","pubTimestamp":1785477023,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Several innovative drug concept stocks showed strength in the afternoon session.As of the latest trading, XTALPI (02228) rose 7.45% to HKD 6.92; GENSCRIPT BIO (01548) climbed 6.4% to HKD 18.3;...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"159992":"创新药","688331":"荣昌生物","HK0000320264.USD":"TAIKANG KAITAI CHINA NEW OPPORTUNITIES FUND \"A\" (USD) ACC","01548":"金斯瑞生物科技","LU2148510915.USD":"FULLERTON LUX FUNDS - CHINA A EQUITIES \"R\" (USD) ACC","LU0043850808.USD":"HSBC GIF ASIA EX JAPAN EQUITY \"AD\" INC","LU0823426308.USD":"法巴中国股票基金","LU0516422440.USD":"FULLERTON LUX FUNDS - ASIA FOCUS EQUITIES \"A\" (USD) ACC","LU0516422366.SGD":"Fullerton Lux Funds - Asia Focus Equities A Acc SGD","LU0051755006.USD":"摩根大通中国A (dist)","LU1064130708.USD":"FULLERTON LUX FUNDS - CHINA A EQUITIES \"I\" (USD) ACC","LU0326950275.SGD":"Schroder ISF China Opportunities A Acc SGD-H","LU0572944931.SGD":"Janus Henderson Horizon China Opportunities A2 SGD","LU2488822045.USD":"ALLIANZ CHINA HEALTHY LIVING \"AT\" (USD) ACC","LU0516423091.SGD":"FULLERTON LUX FUNDS - ASIA FOCUS EQUITIES \"I\" (SGD) ACC","LU0417516902.SGD":"Allianz China Equity Cl AT Acc SGD","BK4585":"ETF&股票定投概念","LU0708995583.HKD":"TEMPLETON CHINA \"A\" (HKD) ACC","BK1583":"高瓴概念","BK1521":"挪威政府全球养老基金持仓","LU1969619763.USD":"EASTSPRING INV CHINA A SHARES GROWTH \"A\" (USD) ACC","LU0327786744.USD":"Janus Henderson Horizon China Opportunities A2 USD","LU0140636845.USD":"施罗德大中华区股票A Acc","LU0823426480.USD":"法巴中国股票经典Dis","HK0000306685.HKD":"TAIKANG KAITAI CHINA NEW OPPORTUNITIES FUND \"A\" (HKD) INC","BK4588":"碎股","LU1242518931.SGD":"Fullerton Lux Funds - Asia Absolute Alpha A Acc SGD","LU1880383366.USD":"东方汇理中国股票基金 A2 (C)","BK1576":"医药外包概念","02228":"晶泰控股","LU0456846285.SGD":"JPMorgan Funds - Greater China A (acc) SGD","LU0359202008.SGD":"Blackrock China Fund A2 SGD-H","LU0979878070.USD":"FULLERTON LUX FUNDS - ASIA ABSOLUTE ALPHA \"A\" (USD) ACC","BK1161":"生物科技","BK1610":"ETF&股票定投概念","HK0000306701.USD":"TAIKANG KAITAI CHINA NEW OPPORTUNITIES FUND \"A\" (USD) INC","LU0052750758.USD":"富兰克林中国基金A Acc","BK1574":"生物医药B类股","02269":"药明生物","LU3063872942.SGD":"FULLERTON LUX FUNDS ASIA EQUITIES \"I\" (SGD) ACC","LU1064131003.USD":"FULLERTON LUX FUNDS - CHINA A EQUITIES \"A\" (USD) ACC","LU0516423174.USD":"FULLERTON LUX FUNDS - ASIA FOCUS EQUITIES \"I\" (USD) ACC","LU0039217434.USD":"HSBC GIF CHINESE EQUITY \"AD\" INC","LU0516422952.EUR":"FULLERTON LUX FUNDS - ASIA FOCUS EQUITIES \"I\" (EUR) ACC","LU0307460666.USD":"EASTSPRING INVESTMENTS CHINA EQUITY \"A\" ACC","LU0588546209.SGD":"Eastspring Investments - China Equity Fund AS SGD","09995":"荣昌生物","LU0856984785.SGD":"HSBC GIF MANAGED SOLUTIONS ASIA FOCUSED GROWTH \"ACH\" (SGDHDG) ACC","LU0359201612.USD":"贝莱德中国基金A2","LU1688375341.USD":"贝莱德中国灵活股票基金","LU1720050803.USD":"安联全方位中国股票基金","LU0456827905.SGD":"JPMorgan Funds - China A (acc) SGD","LU0181495838.USD":"施罗德新兴亚洲A Acc","SG9999002463.SGD":"LionGlobal China Growth SGD","IE00B0JY6N72.USD":"PINEBRIDGE GLOBAL EMERGING MARKETS FOCUS EQUITY \"A\" (USD) ACC","KURE":"KraneShares MSCI All China Health Care Index ETF","LU2039709279.SGD":"MANULIFE GF DRAGON GROWTH \"AA\" (SGDHDG) INC","IBBQ":"Invesco Nasdaq Biotechnology ETF","BK1589":"北水核心资产","LU0417516738.SGD":"Allianz Hong Kong Equity AT Acc SGD","LU0348735423.USD":"ALLIANZ HONG KONG EQUITY \"A\" (USD) INC","VXUS":"国际股票ETF-Vanguard","BK1617":"AI医疗","BK1141":"生命科学工具和服务","SG9999002562.SGD":"LionGlobal Asia Pacific SGD","LU2328871848.SGD":"Eastspring Investments - China A Shares Growth AS SGD","LU0819121731.USD":"HSBC GIF MANAGED SOLUTIONS ASIA FOCUSED GROWTH \"AC\" (USD) ACC","KCAI":"KraneShares China Alpha Index ETF","LU0348825331.USD":"ALLIANZ CHINA EQUITY \"A\" (USD) INC","LU0320764599.SGD":"FTIF - Templeton China A Acc SGD","LU1794554557.SGD":"Allianz All China Equity AT Acc H2-SGD","06978":"永泰生物-B","HK0000320223.HKD":"TAIKANG KAITAI CHINA NEW OPPORTUNITIES FUND \"A\" (HKD) ACC","BK0239":"医药制造","LNGR":"Global X Longevity Thematic ETF","LU1242518857.USD":"FULLERTON LUX FUNDS - ASIA ABSOLUTE ALPHA \"I\" (USD) ACC","MEDX":"HORIZON KINETICS MEDICAL ETF"},"translate_title":"港股风云人物：多只创新药股午盘反弹，金斯瑞生物大涨近8%，瑞美根涨超4%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159992":1,"688331":1,"09995":1,"01548":1,"02269":1,"KCAI":1,"LNGR":1,"IBBQ":1,"MEDX":1,"06978":1,"02228":1,"VXUS":1,"KURE":1},"content_text":"Several innovative drug concept stocks showed strength in the afternoon session.As of the latest trading, XTALPI (02228) rose 7.45% to HKD 6.92; GENSCRIPT BIO (01548) climbed 6.4% to HKD 18.3; REMEGEN (09995) advanced 2.96% to HKD 81.75; and WUXI BIO (02269) increased 2.75% to HKD 38.84.On the policy front, the Shanghai Municipal People's Government issued the \"15th Five-Year Plan for Health Development in Shanghai\" on July 30. The plan outlines enhanced support for the research and development of innovative drugs and medical devices. Specifically, it establishes a mechanism to exempt innovative drugs from the DRG (Diagnosis Related Groups) and DIP (Diagnosis-Intervention Packet) payment caps, sending a positive signal regarding the medical insurance reimbursement environment for these products. Furthermore, the National Essential Medicines List has, for the first time, included innovative drugs on a batch scale, which is expected to improve the clinical accessibility of domestically developed innovative drugs.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}